New strategies aim to get more teens vaccinated against HPV
NCT ID NCT05677360
First seen Nov 01, 2025 · Last updated Jun 19, 2026 · Updated 36 times
Summary
This study looks at whether training healthcare providers and giving parents easy-to-understand information can increase HPV vaccination rates among 11-17 year olds. It involves 564 participants across 8 community health centers in Florida. The goal is to help prevent HPV-related cancers by improving vaccine uptake.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN PAPILLOMA VIRUS (HPV) VACCINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral interventions (training for providers and educational materials for parents)
What this could lead to
If successful, this could show effective ways to increase HPV vaccination rates in underserved communities, helping prevent HPV-related cancers.
What could go wrong
The study is currently suspended, so results may be delayed or not completed. It focuses on vaccination rates, not direct health outcomes, and success depends on real-world implementation.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.